SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.16G137600

Description hypothetical protein

Gene interval Chr16:29468438–29472890 (-), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog NA

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features843Overlap
Maximum supporting SNP records5
Features with ≥2 supporting SNP records157

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 1.2835.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

843 matching features · page 17 of 85

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P00240 Captopril-cysteine disulfide 336.0804 14.298e-12
P00274 Chlorosesamone 292.0510 17.311e-13
P00438 1-Iodononane 254.0504 16.337e-15
P00632 Chlorpheniramine 274.1227 17.907e-13
P00694 Stealthin C 307.0854 16.598e-11
P00725 N-Desmethylaminopyrine 217.1244 12.084e-11
P00731 Progabide 334.0875 15.593e-11
P00856 No candidate annotation 514.0622 14.11e-11
P00872 Styelsamine B 319.1298 11.093e-12
P00940 Fendosal 381.1396 11.509e-11